Variables | value | No. | binomial logistic model | multinomial logistic model | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Total recurrene (N = 57) | Local recurrence (N = 20) | Regional recurrence (N = 12) | Distant recurrence (N = 25) | ||||||||||||||
 | risk ratio | 95% CI | p | risk ratio | 95% CI | p | risk ratio | 95% CI | p | risk ratio | 95% CI | p | ||||||
Surgical approach | Laparoscopy | 392 | reference level | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Laparotomy | 162 | 0.788 | 0.339 | 1.808 | 0.575 | 0.681 | 0.198 | 2.342 | 0.542 | 1.164 | 0.182 | 7.455 | 0.873 | 0.902 | 0.267 | 3.045 | 0.868 | |
Pelvic LN | negative | 418 | reference level | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
positive | 37 | 0.362 | 0.083 | 1.433 | 0.157 | 0.039 | 0.001 | 1.926 | 0.103 | 2.380 | 0.112 | 50.632 | 0.578 | 0.425 | 0.076 | 2.363 | 0.328 | |
not done | 99 | 2.003 | 0.559 | 7.733 | 0.295 | 3.642 | 0.557 | 23.820 | 0.177 | 0.424 | 0.046 | 3.871 | 0.447 | > 100 | > 100 | > 100 | < 0.001 | |
paraaortic LN | Negative | 309 | reference level | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Positive | 27 | 1.912 | 0.500 | 7.923 | 0.352 | 3.051 | 0.267 | 34.840 | 0.369 | 1.740 | 0.114 | 26.460 | 0.690 | 2.473 | 0.479 | 12.760 | 0.279 | |
not done | 218 | 1.023 | 0.313 | 3.007 | 0.968 | 0.741 | 0.133 | 4.126 | 0.732 | 14.820 | 1.407 | 156.100 | 0.025 | 0.000 | 0.000 | 0.000 | < 0.001 | |
LVSI | No | 454 | reference level | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 100 | 1.954 | 0.788 | 4.847 | 0.146 | 2.357 | 0.676 | 8.210 | 0.178 | 3.494 | 0.481 | 25.393 | 0.216 | 1.594 | 0.417 | 6.098 | 0.496 | |
Histology | Endometrioid | 467 | reference level | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Non-endometrioid | 87 | 0.602 | 0.160 | 1.962 | 0.422 | 1.514 | 0.333 | 6.890 | 0.591 | 0.000 | 0.000 | 0.000 | < 0.001 | 0.292 | 0.035 | 2.453 | 0.257 | |
FIGO grade | 1 | 280 | reference level | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
2 | 150 | 1.335 | 0.479 | 3.837 | 0.583 | 0.945 | 0.252 | 3.546 | 0.934 | 1.384 | 0.093 | 20.683 | 0.814 | 2.187 | 0.358 | 13.377 | 0.397 | |
3 | 70 | 0.264 | 0.049 | 1.142 | 0.091 | 0.000 | 0.000 | 0.000 | < 0.001 | 2.044 | 0.108 | 38.800 | 0.634 | 0.450 | 0.047 | 4.346 | 0.490 | |
 N/A | 54 | 1.418 | 0.308 | 7.162 | 0.661 | 0.323 | 0.043 | 2.396 | 0.269 | > 100 | > 100 | > 100 | < 0.001 | 4.970 | 0.334 | 74.020 | 0.245 | |
Parametrial invasion | No | 552 | reference level | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 2 | 34.183 | 6.010 | 305.46 | < 0.001 | 109.94 | 1.595 | 7576.60 | 0.030 | 68.300 | 3.865 | 1206.90 | 0.004 | 36.040 | 3.984 | 325.900 | 0.001 | |
FIGO stage | I II | 492 | reference level | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
III IV | 62 | 0.548 | 0.164 | 1.651 | 0.303 | 0.280 | 0.041 | 1.896 | 0.192 | 0.669 | 0.078 | 5.732 | 0.714 | 0.536 | 0.102 | 2.834 | 0.463 | |
Chemotherapy | No | 397 | reference level | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 157 | 67.174 | 17.750 | 447.497 | < 0.001 | 36.500 | 6.716 | 198.400 | < 0.001 | > 100 | > 100 | > 100 | < 0.001 | > 100 | > 100 | > 100 | < 0.001 | |
Age (Continuous) | age | - | 1.037 | 0.998 | 1.079 | 0.068 | 1.032 | 0.976 | 1.091 | 0.269 | 1.110 | 1.022 | 1.206 | 0.013 | 1.002 | 0.945 | 1.061 | 0.959 |
tumor size (continuous) | size | - | 1.041 | 0.896 | 1.208 | 0.593 | 1.083 | 0.852 | 1.378 | 0.514 | 1.143 | 0.857 | 1.525 | 0.362 | 1.023 | 0.846 | 1.236 | 0.817 |
Myometrial invasion | Â | - | 4.911 | 1.205 | 20.655 | 0.027 | 10.605 | 1.565 | 71.868 | 0.016 | 0.115 | 0.003 | 3.963 | 0.231 | 7.446 | 0.890 | 62.262 | 0.064 |